Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A daily news roundup by McKnight's Senior Living referenced a commentary published in the September 2021 issue of The American Journal of Managed Care®. The commentary, “Hospital at Home: Paying for What It’s Worth,” indicated that a framework centered around cost, quality, and equity is essential to define the value of hospital-at-home programs.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More